"Rising prevalence of diabetes and metabolic disorders" The GLP-1 Drug Market is strongly driven by the increasing prevalence of diabetes and metabolic disorders worldwide
The 24-week trial showed those effects held over months
Inflammatory versus neoplastic, mucinous versus non-mucinous, and duct communication remain the core branch points before surveillance or EUS-FNA is planned
The buyer is responsible for compliance with all applicable local laws governing acquisition, handling, and storage
On the contrary, the researchers noted significantly reduced mortality in the epithalamin treated group compared to patients treated with basic therapy alone [10]
Deficiencies in vitamin B12 can lead to neurological complications, including peripheral neuropathy, cognitive decline, and psychiatric diseases such as depression and psychosis (20, 26, 27)